TONIX (TNXP) Lands Second Managed Medicare Deal for Fibromyalgia Drug Tonmya
Tonix says a second managed Medicare agreement adds about 21 million lives, lifting total payer coverage for Tonmya to roughly 166 million U.S. lives.
Tonix Pharmaceuticals (TNXP) said it has signed a second major managed Medicare agreement for Tonmya, its sublingual cyclobenzaprine tablet for fibromyalgia in adults. The deal is effective immediately and adds roughly 21 million Medicare lives, or 38% of the approximately 55 million Medicare lives in the United States.
